A5068660684- Neuroblastoma Research and Treatments
- Breast Cancer Treatment Studies
- Uterine Myomas and Treatments
- Cancer Genomics and Diagnostics
- BRCA gene mutations in cancer
- Ion channel regulation and function
- Ovarian cancer diagnosis and treatment
- Cancer therapeutics and mechanisms
Ministry of Health of the Russian Federation
2020
The introduction of breast cancer screening programs worldwide led not only to the increase non-invasive carcinoma and stage I percentage but also redistribution biological tumor subtypes in female population screened. proportion is 21,4% our country; predictive value size (T1a, T1b T1c) still undefined. We analyzed clinical morphological characteristics as well prognostic (T1a-c) for recurrence death from progression risk determination 1341 patients with tumors. revealed progressive “small”...
Опухоль матки, гистологически схожая с овариальными опухолями полового тяжа — редкое новообразование, разделяющееся на две группы: эндометриальная стромальная опухоль очагами опухоли (ESTSCLE, тип I) и напоминающая овариальные (UTROSCT, II), имеющие различные, клинические особенности, иммуногистохимические характеристики прогноз. Большинство эндометриальных стромальных опухолей элементов имеют химерные гены, чаще всего JAZF1–SUZ12. Из-за малого числа наблюдений, клинических рекомендаций по...
Neuroblastoma (NB) is the most common extracranial solid tumor of childhood, accounting for 6—10 % all malignant neoplasms in children. One fundamentally important problems clinician stratification risk group and definition treatment tactics patients with NB. In this work, we studied dependence expression CRABP1 protein primary focus metastases on type genetic disorders (amplification MYCN gene, deletion 11q23 locus) effect therapy